Glucose Transporter Type 4
"Glucose Transporter Type 4" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A glucose transport protein found in mature MUSCLE CELLS and ADIPOCYTES. It promotes transport of glucose from the BLOOD into target TISSUES. The inactive form of the protein is localized in CYTOPLASMIC VESICLES. In response to INSULIN, it is translocated to the PLASMA MEMBRANE where it facilitates glucose uptake.
Descriptor ID |
D051275
|
MeSH Number(s) |
D12.776.157.530.500.500.937 D12.776.157.530.937.563.937 D12.776.543.585.500.500.937 D12.776.543.585.937.625.937
|
Concept/Terms |
Glucose Transporter Type 4- Glucose Transporter Type 4
- Insulin-Responsive Glucose Transporter
- Glucose Transporter, Insulin-Responsive
- Insulin Responsive Glucose Transporter
- SLC2A4 Protein
- Solute Carrier Family 2, Facilitated Glucose Transporter, Member 4 Protein
- GLUT4 Protein
- GLUT-4 Protein
- GLUT 4 Protein
|
Below are MeSH descriptors whose meaning is more general than "Glucose Transporter Type 4".
Below are MeSH descriptors whose meaning is more specific than "Glucose Transporter Type 4".
This graph shows the total number of publications written about "Glucose Transporter Type 4" by people in this website by year, and whether "Glucose Transporter Type 4" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 0 | 1 | 1 |
2008 | 0 | 1 | 1 |
2011 | 0 | 1 | 1 |
2015 | 0 | 2 | 2 |
2016 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glucose Transporter Type 4" by people in Profiles.
-
Mandala A, Das N, Bhattacharjee S, Mukherjee B, Mukhopadhyay S, Roy SS. Thioredoxin interacting protein mediates lipid-induced impairment of glucose uptake in skeletal muscle. Biochem Biophys Res Commun. 2016 Oct 28; 479(4):933-939.
-
Bhattacharjee S, Das N, Mandala A, Mukhopadhyay S, Roy SS. Fenofibrate Reverses Palmitate Induced Impairment in Glucose Uptake in Skeletal Muscle Cells by Preventing Cytosolic Ceramide Accumulation. Cell Physiol Biochem. 2015; 37(4):1315-28.
-
Kee AJ, Yang L, Lucas CA, Greenberg MJ, Martel N, Leong GM, Hughes WE, Cooney GJ, James DE, Ostap EM, Han W, Gunning PW, Hardeman EC. An actin filament population defined by the tropomyosin Tpm3.1 regulates glucose uptake. Traffic. 2015 Jul; 16(7):691-711.
-
Ciccarelli M, Chuprun JK, Rengo G, Gao E, Wei Z, Peroutka RJ, Gold JI, Gumpert A, Chen M, Otis NJ, Dorn GW, Trimarco B, Iaccarino G, Koch WJ. G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia. Circulation. 2011 May 10; 123(18):1953-62.
-
Nojima M, Huang Y, Tyagi M, Kao HY, Fujinaga K. The positive transcription elongation factor b is an essential cofactor for the activation of transcription by myocyte enhancer factor 2. J Mol Biol. 2008 Oct 03; 382(2):275-87.
-
Moadel RM, Weldon RH, Katz EB, Lu P, Mani J, Stahl M, Blaufox MD, Pestell RG, Charron MJ, Dadachova E. Positherapy: targeted nuclear therapy of breast cancer with 18F-2-deoxy-2-fluoro-D-glucose. Cancer Res. 2005 Feb 1; 65(3):698-702.